Lunch With FTI: Opioids & Controlled Substances: Addressing Provider Risk

Date: Wednesday, October 17, 2018
Length: 30 minutes

Why Watch?

Prescription drug abuse has become an epidemic in the United States and a top priority for law enforcement agencies. As a result, health systems face significant regulatory, financial and reputational risks when handling opioids and controlled substances. Join us as we discuss approaches for identifying and addressing compliance risks related to controlled substances and drug diversion in the healthcare provider setting.

Learn About:

Impact of drug diversion on health systems
Internal and external risks associated with opioids and controlled substances
Methods for identifying and assessing compliance risks
Controls to minimize opportunities for drug diversion
Incorporating data analytics and data visualization tools into compliance programs

Who Should Watch?

Hospital C-Suite Executives
General Counsel
Compliance Officers
Healthcare Attorneys
Hospital Pharmacy Managers / Pharmacists in Charge

Presenters:

Caroline Conneely
Managing Director
FTI Consulting Health Solutions

Caroline Conneely is a Managing Director in FTI Consulting’s Health Solutions practice and is based in Washington, D.C. Ms. Conneely works primarily on regulatory matters in the healthcare and life sciences industries, assisting clients and their counsel in evaluating and managing regulatory and compliance risks; responding to and investigating allegations of fraud and other potential regulatory violations; and identifying opportunities for procedural and operational improvements. These engagements typically include the evaluation of existing and historical systems, processes and controls; the analysis and quantification of potential financial exposure; and the development of integrated analytics and reporting tools to monitor compliance. Her clients include hospital systems and post-acute healthcare providers; companies throughout the pharmaceutical supply chain including manufacturers, drug wholesalers, prescribers and retail pharmacies; and commercial insurance plans..

David DuBois
Director
FTI Consulting Health Solutions

David DuBois is a Director in the Health Solutions practice of FTI Consulting in Washington D.C. Mr. DuBois’ experience in the healthcare industry includes leveraging large data sets and creating statistical models to generate insights that add value to a company’s internal processes and bottom line. Mr. DuBois has used this expertise to structure settlement models in response to government investigations, develop key performance indicators, and re-engineer major business functions to assist clients in meeting legal and regulatory obligations. In his work, David has worked with clients across the healthcare industry, such as health systems, insurance providers, and firms throughout the pharmaceutical supply chain, including manufacturers, distributors, and retail pharmacies.

Rachel Pinkham
Senior Consultant
FTI Consulting Health Solutions

Rachel Pinkham is a Senior Consultant in the Health Solutions practice and is based in Washington, D.C. Ms. Pinkham’s experience has focused on helping clients across the healthcare industry utilize data analytics and statistical models to improve processes and mitigate regulatory and compliance risks. In this work, Ms. Pinkham has developed powerful data visualizations to guide clients in identifying opportunities to manage risk, as well as assisting clients responding to investigations or facing litigation.